Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive approach. Supporters often stress the possibility for significant therapeutic outcomes, especially in ailments where conventional therapies have proven inadequate. However, this is to assess the considerable financial burden associated with CPI stem cell therapy, s